Next, we analyzed S100A16 expression in glioma U87, U251, T98G, LN229, A172, SW1738, N3 cells and control NHA cells by western blot, and showed different levels of S100A16 proteins (Fig. 4E). This evidence concerns the gene S100A16 and central nervous system cancer.